Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
15.44
+0.02 (0.13%)
At close: Dec 12, 2025, 4:00 PM EST
15.57
+0.13 (0.84%)
After-hours: Dec 12, 2025, 6:54 PM EST
Adaptive Biotechnologies Employees
Adaptive Biotechnologies had 619 employees as of December 31, 2024. The number of employees decreased by 90 or -12.69% compared to the previous year.
Employees
619
Change (1Y)
-90
Growth (1Y)
-12.69%
Revenue / Employee
$408,326
Profits / Employee
-$128,614
Market Cap
2.36B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 619 | -90 | -12.69% |
| Dec 31, 2023 | 709 | -81 | -10.25% |
| Dec 31, 2022 | 790 | -68 | -7.93% |
| Dec 31, 2021 | 858 | 236 | 37.94% |
| Dec 31, 2020 | 622 | 169 | 37.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ADPT News
- 3 days ago - Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease - GlobeNewsWire
- 6 days ago - Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting - GlobeNewsWire
- 7 days ago - Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal? - Benzinga
- 18 days ago - Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting - GlobeNewsWire
- 5 weeks ago - Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Adaptive Biotechnologies Corporation (ADPT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025 - GlobeNewsWire